Skip to main content

HEALTH

  • Bloomberg: B&L on sales block for as much as $10 billion

    NEW YORK — According to a Bloomberg report published Friday morning, Abbott Laboratories, Johnson & Johnson and Sanofi are all potential suitors for Bausch & Lomb's eye care business in a deal that could be valued as high as $10 billion. 

    B&L is being shopped by private equity firm Warburg Pincus, which is working with Goldman Sachs Group, Bloomberg reported, and both Abbott and Sanofi have contracted financial advisors as well. 

    Other companies who have been invited to bid include Merck and Pfizer. 

  • Intimacy health to make a big showing at the 2013 Consumer Electronics Show

    LAS VEGAS — Technology and sexual health will merge at the 2013 International Consumer Electronics Show here with executives from Standard Innovation making feature presentations and Church & Dwight targeting the show with a personal massager giveaway as part of its campaign to initiate a trial that started in November 2012. 

  • March of Dimes highlights folic acid for pregnant women

    WHITE PLAINS, N.Y. — The March of Dimes is launching a campaign to encourage expectant mothers to take folic acid to prevent birth defects, the group said Friday.

    The group announced national Folic Acid Awareness Week, reminding pregnant women to take vitamin B. The vitamin is known to prevent birth defects like spina bifida and anencephaly, collectively known as neural tube defects. NTDs occur in the first few weeks following conception, often before a woman knows she is pregnant.

  • Mintel: Declining user base means smoking cessation aids will experience slow growth through 2017

    CHICAGO — Sales of smoking cessation aids are projected to reach $1 billion in 2012 with continued growth driving sales as high as $1.2 billion by 2017, market research firm Mintel reported Thursday. 

  • Novo Nordisk appoints Curtis Oltmans as corporate VP, general counsel for legal and quality affairs

    PRINCETON, N.J. — Novo Nordisk has appointed Curtis Oltmans as its corporate VP and general counsel for legal and quality affairs, the company said Friday.

    In the new role, for which he will also join the company's U.S. executive team, Oltmans will be handle issues like law, quality, intellectual property, grants and philanthropy for the Danish drug maker's North American business.

  • 'The Biggest Loser' starts off season 14 with a fitness challenge to all Americans and a revamped web page

    UNIVERSAL CITY, Calif. — NBCUniversal Television Consumer Products, in conjunction with Shine America, on Thursday announced the launch of the newly enhanced Biggestloser.com to serve as a one-stop portal with complete access to NBC’s “The Biggest Loser” online community.

  • CRN celebrates 40 years championing the dietary supplement industry

    WASHINGTON — The Council for Responsible Nutrition on Thursday kicked off a year-long celebration in honor of the association’s 40th anniversary. Created in 1973 by three companies and a single staffer, CRN is today recognized by many, both inside and outside the industry, as the leading trade association representing more than 100 dietary supplement manufacturers, ingredient suppliers and companies that supply services for the supplement industry.

  • NCPA: Congress' 'fiscal cliff' bill could force independents out of Medicare diabetes business

    ALEXANDRIA, Va. — While the "fiscal cliff" bill heads off the most severe tax implications for most Americans, the 25.8 million Americans with diabetes may find this bill a bitter pill to swallow, suggested the National Community Pharmacists Association in a press release issued Wednesday. 

X
This ad will auto-close in 10 seconds